Test Code MDMA MDMA (ECSTASY) SCREEN WITH GC-MS, CONFIRMATION, URINE
Additional Codes
Software | Test Code |
---|---|
SoftID | MDMA |
EPIC | LAB407 |
Performing Laboratory
NorDx Laboratories
Useful For
The screening assay detects MDMA (Ecstasy) in urine.
Method Name
Enzyme Immunoassay (EIA)
Gas Chromatography-Mass Spectrophotometry (GC-MS) (If indicated)
Reference Values
Not Detected
EIA cutoff concentration: 500 ng/mL
GC-MS cutoff concentrations:
Amphetamine: < 50 ng/mL
Methamphetamine: < 50 ng/mL
MDMA (Ecstasy): < 50 ng/mL
MDA (Ecstasy metabolite): < 50 ng/mL
Phentermine: < 500 ng/mL
Pseudoephedrine / Ephedrine: < 500 ng/mL
Phenylpropanolamine: < 500 ng/mL
For help with interpretation please call: 877-323-0045
Please see test code AMUR for additional MDMA confirmatory testing information.
Days and Times Test Performed
Monday through Friday
Report Available
1 Day
if Negative
Specimen Type
Urine, Random
Preferred Container
Urine Cup
Preferred Volume
Urine, Random: 25 mL (Urine Cup)
Minimum Volume
Urine, Random: 10 mL (Urine Cup)
Specimen Collection and Handling
Collect random urine and send refrigerated in a clean, non-sterile urine container.
Specimen Stability Information
Specimen Type: Urine, Random
Refrigerated: 7 Days
Add On Capable
Not Permitted
Advance Beneficiary Notice Requirements
No ABN Required
CPT Code Information
CPT Code |
CPT Description |
CPT Disclaimer |
---|---|---|
80307 | Drug Test, Presumptive Screening, By Instrument Chemistry (i.e Immunoassay, Chromatography, and Mass Spectrometry) | |
80359 | Methylenedioxyamphetamines (MDA, MDEA, MDMA) | if Indicated |
Performing Laboratory Location
NorDx Laboratories
Maximum Laboratory Time
4 Days
LOINC Code Information
19568-5
Clinical Significance
If the MDMA screen is ≥ 500 ng/mL, the amphetamines confirmation/quantitation by GC-MS is performed at an additional charge.
This test is intended for clinical monitoring and management of patients. It is not intended for non-medical use such as employment or forensic testing.
Specific gravity, pH, creatinine and oxidants will be performed and reported at no additional charge to identify potential adulteration of the urine specimen.